Information de reference pour ce titreAccession Number: | 00004836-200110000-00004.
|
Author: | Gill, Satinder S. M.D.; Heuman, Douglas M. M.D.; Mihas, Anastasios A. M.D.
|
Institution: | From the Division of Gastroenterology, Medical College of Virginia, Commonwealth Virginia University, Richmond, Virginia, U.S.A. (S.S.G., D.M.H., A.A.M.); and McGuire Veterans Affairs Medical Center, Richmond, Virginia, U.S.A. (D.M.H., A.A.M.).
|
Title: | |
Source: | Journal of Clinical Gastroenterology. 33(4):267-282, October 2001.
|
Abstract: | Small intestinal neoplasms are uncommonly encountered in clinical practice. They may occur sporadically, in association with genetic diseases (e.g., familial adenomatous polyposis coli or Peutz-Jeghers syndrome), or in association with chronic intestinal inflammatory disorders (e.g., Crohn's disease or celiac sprue). Benign small intestinal tumors (e.g., leiomyoma, lipoma, hamartoma, or desmoid tumor) usually are asymptomatic but may present with intussusception. Primary malignancies of the small intestine-including adenocarcinoma, leiomyosarcoma, carcinoid, and lymphoma-may present with intestinal obstruction, jaundice, bleeding, or pain. Extraintestinal neoplasms may involve the intestine via contiguous spread or peritoneal metastasis. Hematogenous metastases to the intestine from an extraintestinal primary are unusual and are most typical of melanoma. Because the small intestine is relatively inaccessible to routine endoscopy, diagnosis of small intestinal neoplasms is often delayed for months after onset of symptoms. When the diagnosis is suspected, enteroclysis is the most useful imaging study. Small bowel endoscopy (enteroscopy) is increasingly widely available and may permit earlier, nonoperative diagnosis.
(C) 2001 Lippincott Williams & Wilkins, Inc.
|
Author Keywords: | Small intestinal neoplasms; Small bowel tumors; Metastatic neoplasms.
|
References: | 1. Neugut AI, Jacobson JS, Suh S, et al. The epidemiology of cancer of the small bowel. Cancer Epidemiol Biomarkers Prev 1999; 7: 243-51.
2. Barelay TH, Schapira DV. Malignant tumors of the small intestine. Cancer 1983; 51: 878-81.
3. Attanoos R, Williams GT. Epithelial and neuroendocrine tumors of the duodenum. Semin Diagn Pathol 1991; 8: 149-62.
4. O'Riordan BG, Vilor M, Herrera L. Small bowel tumors: an overview. Dig Dis Sci 1996; 14: 245-57.
5. Lee YT. Leiomyosarcoma of the gastrointestinal tract: general pattern of metastasis and recurrence. Cancer Treat Rev 1983; 10: 91-101.
6. Lowenfels AB. Why are small bowel tumors so rare? Lancet 1973;1:24-6.
7. Wettenberg LW. Studies of polycyclic hydrocarbon hydroxylases of the intestine possibly related to cancer. Effect of diet on benzpyrene hydroxylase activity. Cancer 1971; 8: 99-102.
8. Chow WH, Linet MS, McLaughlin JK, et al. Risk factors for small intestine cancer. Cancer Causes Control 1993; 4: 163-9.
9. Kawashima A, Goldman SM, Fishman EK, et al. CT of intraabdominal desmoid tumors: is the tumor different in patients with Gardner's disease? Am J Roentgenol 1994;162:339-42.
10. Maglinte DD, O'Connor K, Chernish SM, et al. The role of the physician in the late diagnosis of primary malignant tumors of the small intestine. Am J Gastroenterol 1991; 86: 304-8.
11. Bender GN, Maglinte DD, Kloppel VR, et al. CT enteroclysis: a superfluous diagnostic procedure or valuable when investigating small-bowel disease? Am J Roentgenol 1999;172:373-8.
12. Buckley JA, Jones B, Fishman EK. Small bowel cancer: imaging features and staging. Radiol Clin N Am 1997; 35: 381-402.
13. Maccioni F, Rossi P, Gourtsoyiannis N, et al. US and CT findings of small bowel neoplasms. Eur Radiol 1997; 7: 1398-409.
14. Buckley JA, Fishman EK. CT evaluation of small bowel neoplasms: spectrum of disease. Radiographics 1998; 18: 379-92.
15. Gourtsoyiannis N, Mako E. Imaging of primary small intestinal tumors by enteroclysis and CT with pathologic correlation. Eur Radiol 1997; 7: 625-42.
16. Debatin JF, Patak MA. MRI of the small and large bowel. Eur Radiol 1999; 9: 1523-34.
17. Lee JK, Marcos HB, Semelka RC. MR imaging of the small bowel using the HASTE sequence. Am J Roentgenol 1998; 170: 1457-63.
18. Bhutani MS, Hawes RH, Hoffman BJ. A comparison of the accuracy of echo features during endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration for diagnosis of malignant lymph node invasion. Gastrointest Endosc 1997; 45: 474-9.
19. Cannon ME, Carpenter SL, Elta GH, et al. EUS compared with CT, magnetic resonance imaging, and angiography and the influence of biliary stenting on staging accuracy of ampullary neoplasms. Gastrointest Endosc 1999; 50: 27-33.
20. Shoup M, Hodut P, Aranha GV, et al. Defining a role for endoscopic ultrasound in staging periampullary tumors. Am J Surg 2000; 179: 453-6.
21. Lewis BS. The history of enteroscopy. Gastrointest Endosc Clin N Am 1999; 9: 1-11.
22. Oates BC, Morris AI. Enteroscopy. Curr Opin Gastroenterol 2000; 16: 121-5.
23. Swain CP. The role of enteroscopy in clinical practice. Gastrointest Endosc Clin N Am 1999; 9: 135-44.
24. Lewis BS. Radiology versus endoscopy of the small bowel. Gastrointest Endosc Clin N Am 1999; 9: 13-27.
25. Forouzandeh B, Wright R. Diagnostic yield of push-type enteroscopy in relation to indication. Gastrointest Endosc 1998; 48: 645-7.
26. Delmotte JS, Gay GJ, Houcke PH, et al. Intraoperative endoscopy. Gastrointest Endosc Clin N Am 1999; 9: 61-9.
27. Ingrosso M, Prete F, Pisani A, et al. Laparoscopically assisted total enteroscopy: A new approach to small intestinal diseases. Gastrointest Endosc 1999; 49: 651-3.
28. Gong F, Swain P, Mills TN. Wireless endoscopy. Gastrointest Endosc 2000; 51: 725-9.
29. Blanchard DK, Budde JM, Hatch III GF, et al. Tumors of the small intestine. World J Surg 2000; 24: 421-9.
30. Starr GF, Dockerty MB. Leiomyomas and leiomyosarcomas of the small intestine. Cancer 1955; 8: 101-11.
31. Miettinen M, Sobin LH, Sarlomo-Rikala M. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117(KIT). Mod Pathol 2000; 13: 1134-42.
32. Bjork KJ, Davis CJ, Nagornegi DM, et al. Duodenal villous tumors. Arch Surg 1990; 125: 961-5.
33. Witteman BJ, Janssen AR, Griffioen G, et al. Villous tumors of the duodenum: An analysis of the literature with emphasis on malignant transformation. Neth J Med 1993; 42: 5-11.
34. Levine JA, Burgart LS, Batts KP, et al. Brunner's gland hamartomas: clinical presentation and pathologic features of 27 cases. Am J Gastroenterol 1995; 90: 290-4.
35. Shemesh E, Horin SB, Barshack I, et al. Brunner's gland hamartoma presenting as a large duodenal polyp. Gastrointest Endosc 2000; 52: 435-6.
36. Block KP, Frick TJ, Warner TFSC. Gastrointestinal bleeding from a Brunner's gland hamartoma: Characterization by endoscopy, computed tomography, and endoscopic ultrasound. Am J Gastroenterol 2000; 95: 1581-3.
37. Morgan DR, Mylankal K, Barghouti N, et al. Small bowel hemangioma with local lymph node involvement presenting as intussusception. J Clin Pathol 2000; 53: 552-3.
38. Makko EK. Small bowel hemangiomatosis in a patient with Maffucci's and blue-rubber-bleb-nevus syndromes. AJR Am J Roentgenol 1996; 166: 1499-500.
39. Ramanujam PS, Venkatesh KS, Bettinger L, et al. Hemangioma of the small intestine: case report and literature review. Am J Gastroenterol 1995; 90: 2063-4.
40. Al Samman M, Zuckerman MJ, Mohandas A, et al. Intestinal nodular lymphoid hyperplasia in a patient with chronic diarrhea and recurrent sinopulmonary infections. Am J Gastroenterol 2000; 95: 2147-8.
41. Brucher BL, Roder JD, Fink U, et al. Prognostic factors in resected primary small bowel tumors. Dig Surg 1998; 15: 42-51.
42. Ojha A, Zacherl J, Scheuba C, et al. Primary small bowel malignancies: single-center results of three decades. J Clin Gastroenterol 2000; 30: 289-93.
43. Neugut AI, Marvin MR, Rella VA, et al. An overview of adenocarcinoma of the small intestine. Oncology 1997; 11: 529-36.
44. Negri E, Bosetti C, La Vecchia C, et al. Risk factors for adenocarcinoma of the small intestine. Cancer 1999; 82: 171-4.
45. Kaerlev L, Teglbjaers PS, Sabroe S, et al. Is there an association between alcohol intake or smoking and small bowel adenocarcinoma? Results from a European multicenter case-control study. Cancer Causes Control 2000; 11: 791-7.
46. Kaerlev L, Teglbjaers PS, Sabroe S, et al. Occupation and small bowel adenocarcinoma: a European case-control study. Occup Environ Med 2000; 57: 760-6.
47. Petras RE, Miz-Madjlessi SH, Farmer RG. Crohn's disease and intestinal carcinoma. Gastroenterology 1987; 93: 1307-14.
48. Swinson CM, Slavin G, Coles EC, et al. Celiac disease and malignancy. Lancet 1983; 1: 111-5.
49. Jones TS, Marshall TL. Neurofibromatosis and small bowel adenocarcinoma: an unrecognized association. Gut 1987; 28: 1173-6.
50. Stone AR, Davies N, Stephenson TP. Carcinoma associated with augmentation cystoplasty. Br J Urol 1987; 60: 236-8.
51. Meretyk S, Landau EH, Okon E, et al. Adenocarcinoma in an ileal conduit: a late recurrence of urethral adenocarcinoma. J Urol 1987; 138: 859-60.
52. Sellner F. Investigations on the significance of the adenoma-carcinoma sequence in the small bowel. Cancer 1990; 66: 702-15.
53. Kurtz RC, Sternberg SS, Miller HH, et al. Upper gastrointestinal neoplasia in familial polyposis. Dig Dis Sci 1987; 32: 459-65.
54. Jagelman DG, DeCosse JJ, Bussey JJ. Upper gastrointestinal cancer in familial adenomatous polyposis. Lancet 1988; 1: 1149-51.
55. Minardi AJ, Zibari GB, Aultman DF, et al. Small bowel tumors. J Am Coll Surg 1998; 186: 664-8.
56. Michelassi F, Testa G, Pomidor WJ, et al. Adenocarcinoma complicating Crohn's disease. Dis Colon Rectum 1993; 36: 654-61.
57. Howe JR, Karnell LH, Menck HR, et al. The American College of Surgeons Commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: review of the National Cancer Data Base, 1985-1995. Cancer 1999; 86: 2693-706.
58. North JH, Pack MS. Malignant tumors of the small intestine: a review of 114 cases. Am Surg 2000; 66: 46-51.
59. Norton ID, Gostout CJ. Management of periampullary adenoma. Dig Dis 1998; 16: 266-73.
60. Matsumoto T, Iida M, Nakamura S, et al. Natural history of ampullary adenoma in familial adenomatous polyposis: reconfirmation of benign nature during extended surveillance. Am J Gastroenterol 2000; 95: 1557-62.
61. Talamini MA, Moesinger RC, Pitt HA, et al. Adenocarcinoma of the ampulla of Vater. A 28-year experience. Ann Surg 1997; 225: 590-600.
62. Trzyna W, McHugh M, McCue P, et al. Molecular determination of the malignant potential of smooth muscle neoplasms. Cancer 1997; 80: 211-7.
63. Dougherty MJ, Compton C, Talbert M, et al. Sarcomas of the gastrointestinal tract. Separation into favorable and unfavorable prognostic groups by mitotic count. Ann Surg 1991; 214: 569-74.
64. Chiotasso PJ, Fazio VW. Prognostic factors of 28 leiomyosarcomas of the small intestine. Surg Gynecol Obstet 1982; 155: 197-202.
65. Crump M, Gospodarowicz M, Shepherd FA. Lymphoma of the gastrointestinal tract. Semin Oncol 1999; 26: 324-7.
66. D'Amore F, Christensen BE, Brincker H, et al. Clinicopathologic features and prognostic factors in extranodal non-Hodgkin's lymphomas. Danish LYFO Study Group. Eur J Cancer 1991; 27: 1201-8.
67. Ducreux M, Boutron MC, Piard F, et al. A 15-year series of gastrointestinal non-Hodgkin's lymphomas: a population based study. Br J Cancer 1998; 77: 511-4.
68. Weingrad DN, DeCosse JJ, Sherlock P, et al. Primary gastrointestinal lymphoma: a 30-year review. Cancer 1982; 49: 1258-65.
69. Disario JA, Burt RW, Vargas H, et al. Small bowel cancer: epidemiological and clinical characteristics from a population-based study. Am J Gastroenterol 1994; 89: 699-701.
70. Pagtalunan RS, Mayo CW, Dockerty MB. Primary malignant tumors of the small intestine. Am J Surg 1964; 108: 13-8.
71. Gray GM, Rosenberg SA, Cooper AD, et al. Lymphomas involving the gastrointestinal tract. Gastroenterology 1982; 82: 143-52.
72. Musshof K. Klinische stadieneinteilung der Nicht-Hodgkin lymphoma. Strahlertherapie 1977; 153: 218-21.
73. Rohatiner A, D'Amore F, Coiffier B, et al. Report on a workshop convened to discuss the pathologic and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 1994; 5: 397-400.
74. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-92.
75. Liang R, Todd D, Chan K, et al. Prognostic factors for primary gastrointestinal lymphoma. Hematol Oncol 1995; 13: 153-63.
76. Zinzani PL, Magagnoli M, Pagliani G, et al. Primary intestinal lymphoma: clinical and therapeutic features of 32 patients. Hematologica 1997; 82: 305-8.
77. Domizio P, Owen RA, Shepherd NA, et al. Primary lymphoma of the small intestine: A clinicopathologic study of 119 cases. Am J Surg Pathol 1993; 17: 429-42.
78. Isaacson PG. Mucosa-associated lymphoid tissue lymphoma. Semin Hematol 1999; 36: 139-41.
79. Burkard P, Lance P. Mucosa-associated lymphoid tissue and other gastrointestinal lymphomas. Curr Opin Gastroenterol 2000; 16: 107-12.
80. Kaila VL, El-Newihi HM, Dreiling BJ, et al. Waldenstrom's macroglobulinemia of the stomach presenting with upper gastrointestinal hemorrhage. Gastrointest Endosc 1996; 44: 73-5.
81. Lauffer JM, Zhang T, Modlin IM. Review article: current status on gastrointestinal carcinoids. Aliment Pharmacol Ther 1999; 13: 271-87.
82. Hofmann JW, Fox PS, Milwaukee DSW. Duodenal well tumors and the Zollinger-Ellison syndrome. Arch Surg 1973; 107: 334-8.
83. Solcia E, Fiocca R, Rindi G, et al. Endocrine tumors of the small and large intestine. Path Res Pract 1995; 191: 366-72.
84. Hamid QA, Bishop AE, Rode J, et al. Duodenal gangliocytic paragangliomas: a study of 10 cases with immunocytochemical neuroendocrine markers. Hum Pathol 1986; 17: 1151-7.
85. Krejs GJ, Orei L, Conlon JM, et al. Somatostatinoma syndrome: biochemical, morphologic and clinical features. N Engl J Med 1979; 301: 285-92.
86. Prevot S, Bienvenu L, Vaillant JC, et al. Benign schwannoma of the digestive tract: clinicopathologic and immunohistochemical study of five cases, including a case of esophageal tumor. Am J Surg Pathol 1999; 23: 431-6.
87. Cellier C, Yaghi C, Cuillerier E, et al. Metastatic jejunal vipoma: beneficial effect of combination therapy with interferon-a and 5-fluorouracil. Am J Gastroenterol 2000; 95: 289-93.
88. Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer 1997; 79: 813-29.
89. Kulke MH, Meyer RJ. Carcinoid tumors. N Engl J Med 1999; 340: 858-68.
90. Feldman JM, O'Dorisio TM. Role of neuropeptides and serotonin in the diagnosis of carcinoid tumors. Am J Med 1986; 81 (Suppl 6B): 41-8.
91. Lundin L, Norheim I, Landelius J, et al. Carcinoid heart disease: relationship of circulating vasoactive substances to ultrasound-detectable cardiac abnormalities. Circulation 1988; 77: 264-9.
92. Pellikka PA, Tajik AJ, Khandheria BK, et al. Carcinoid heart disease: clinical and echocardiographic spectrum in 74 patients. Circulation 1993; 87: 1188-96.
93. Makridis C, Oberg K, Suhlin C, et al. Surgical treatment of mid-gut carcinoid tumors. World J Surg 1990; 14: 377-383.
94. Lamberts SW, Bakker WH, Reubi JC, et al. Somatostatin-receptor imaging in the localization of endocrine tumors. N Engl J Med 1990; 323: 1246-49.
95. Creutzfeldt W, Stockmann F. Carcinoids and carcinoid syndrome. Am J Med 1987; 82 (Suppl 5B): 4-16.
96. Stinner B, Kisker O, Zielke A, et al. Surgical management for carcinoid tumors of small bowel, appendix, colon and rectum. World J Surg 1996; 20: 183-8.
97. Reubi JC, Kvols LK, Waser B, et al. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. Cancer Res 1990; 50: 5969-77.
98. Krenning EP, Kwekkenboom DJ, Oei HY, et al. Somatostatin-receptor scintigraphy in gastroenteropancreatic tumors: an overview of European results. Ann N Y Acad Sci 1994; 733: 416-24.
99. Kvols LK, Moertel CG, O'Connell MJ, et al. Treatment of the malignant carcinoid syndrome: evaluation of a long acting somatostatin analogue. N Engl J Med 1986; 315: 663-6.
100. Ruszniewski P, Ducreux M, Chayvialle JA, et al. Treatment of the carcinoid syndrome with the long acting somatostatin analogue lanreotide: a prospective study in 39 patients. Gut 1996; 39: 279-83.
101. Kitagawa S, Townsend BL, Hebert AA. Peutz-Jeghers syndrome. Dermatol Clin 1995; 13: 127-33.
102. Westerman AM, Wilson JH. Peutz-Jeghers syndrome: risks of a hereditary condition. Scand J Gastroenterol Suppl 1999; 230: 64-70.
103. Buck JL, Harned RK, Lichtenstein JE, et al. Peutz-Jeghers syndrome. Radiographics 1992; 12: 365-78.
104. Hemminki A. The molecular basis and clinical aspects of Peutz-Jeghers syndrome. Cell Mol Life Sci 1999; 55: 735-50.
105. Westerman AM, Entius MM, Boor PP, et al. Novel mutations in the LKB1/STK11 gene in Dutch Peutz-Jeghers families. Hum Mutat 1999; 13: 476-81.
106. Westerman AM, Gutius MM, de Baar E, et al. Peutz-Jeghers syndrome: 78 year follow-up of the original family. Lancet 1999; 353: 1211-5.
107. Rossini FP, Risio M, Pennazio M. Small bowel tumors and polyposis syndromes. Gastrointest Endosc Clin N Am 1999; 9: 93-114.
108. Pennazio M, Rossini FP. Small bowel polyps in Peutz-Jeghers syndrome: management by combined push enteroscopy and intraoperative endoscopy. Gastrointest Endosc 2000; 51: 304-8.
109. Isaacson PG, O'Connor NTG, Spencer J, et al. Malignant histocytosis of the intestine: a T-cell lymphoma. Lancet 1985; 2: 688-91.
110. Wright DH. Enteropathy associated T-cell lymphoma. Cancer Surv 1997; 30: 249-61.
111. Cellier C, Delabesse E, Helmer C, et al. Refractory sprue, celiac disease and enteropathy-associated T-cell lymphoma. Lancet 2000; 356: 203-8.
112. Fine KD, Stone MJ. [alpha]-heavy chain disease, Mediterranean lymphoma and immunoproliferative small intestinal disease: a review of clinicopathologic features, pathogenesis, and differential diagnosis. Am J Gastroenterol 1999; 94: 1139-52.
113. Isaacson PG. Gastrointestinal lymphoma. Hum Pathol 1994; 25: 1020-9.
114. Arista-Nasr J, Gonzales-Romo MA, Mantilla-Morales A, et al. Immunoproliferative small intestinal disease in Mexico: report of four cases and review of the literature. J Clin Gastroenterol 1994; 18: 67-71.
115. Khojasteh A, Haghshenass M, Haghighi P. Immunoproliferative small bowel disease: a "third-world lesion." N Engl J Med 1983; 308: 1401-5.
116. Rappaport H, Ramot B, Hulu N, et al. The pathology of so-called Mediterranean lymphoma with malabsorption. Cancer 1972; 29: 1502-11.
117. Rambaud JC, Modigliani R, Phuoc BK, et al. Non-secretory alpha-chain disease in intestinal lymphoma [letter]. N Engl J Med 1980; 303: 53.
118. Hall PA, Jass JR, Levinson DA. Malignant lymphoma of the gastrointestinal tract. Semin Diagn Pathol 1991; 8: 163-77.
119. Rambaud JC. Small intestinal lymphomas and alpha-chain disease. Clin Gastroneterol 1983; 12: 743-6.
120. Al-Mondhiry H. Primary lymphomas of the small intestine: East-West contrast. Am J Hematol 1986; 22: 89-105.
121. Halphen M, Najjar T, Jaafoura H, et al. Diagnostic value of upper intestinal fiber endoscopy in primary small intestinal lymphoma: a prospective study by the Tunisian-French Intestinal Lymphoma Group. Cancer 1986; 58: 2140-5.
122. Matuchansky C, Cogne M, Lemaire M, et al. Non-secretory a-chain disease with immuno-proliferative small-intestinal disease. N Engl J Med 1989; 320: 1534-9.
123. Seligman M. Immunochemical, clinical, and pathologic features of a-chain disease. Arch Intern Med 1975; 135: 78-82.
124. Anonymous. Alpha-chain disease and related small intestinal lymphoma: a memorandum. Bull WHO 1976;54:615-24.
125. Salem PA, Nassar VH, Shahid MJ, et al. Mediterranean abdominal lymphoma, or immunoproliferative small intestinal disease. Part I: clinical aspects. Cancer 1977; 40: 2941-7.
126. Galian A, Lecestre MJ, Scotto J, et al. Pathological study of alpha-chain disease with special emphasis on evolution. Cancer 1977; 39: 2081-101.
127. el Saghi NS, Jessen K, Mass RE, et al. Combination chemotherapy for primary small intestinal lymphoma in the Middle East. Eur J Cancer Clin Oncol 1989; 25: 851-6.
128. O'Keefe SJ, Winter TA, Newton KA, et al. Severe malnutrition associated with alpha-chain disease: response to tetracycline and intensive nutritional support. Am J Gastroenterol 1988; 83: 995-1001.
129. Salimi M, Spinelli JJ. Chemotherapy of Mediterranean abdominal lymphoma: retrospective comparison of chemotherapy protocol in Iranian patients. Am J Clin Oncol 1996; 19: 18-22.
130. Akbulut H, Soykan I, Yakaryilmaz F, et al. Five-year results of the treatment of 23 patients with immunoproliferative small intestinal disease. Cancer 1997; 80: 8-14.
131. Fischbach W, Tacke W, Greiner A, et al. Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori. Lancet 1997; 349: 31-2.
132. Lewis JD, Deren JJ, Lichtenstein GR. Cancer risk in patients with inflammatory bowel disease. Gastroenterol Clin N Am 1999; 28: 459-77.
133. Bernstein D, Rogers A. Malignancy in Crohn's disease. Am J Gastroenterol 1996; 91: 434-40.
134. Glotzer DJ. The risk of cancer in Crohn's disease. Gastroenterology 1985; 89: 438-41.
135. Savoca PE, Ballantyne GH, Cahow CE. Gastrointestinal malignancies in Crohn's disease: a 20 year experience. Dis Colon Rectum 1990; 33: 7-11.
136. Ribeiro MB, Greenstein AJ, Heimann TM, et al. Adenocarcinoma of the small intestine in Crohn's disease. Surg Gynecol Obstet 1991; 173: 343-9.
137. Loftus EV, Tremaine WJ, Habermann TM, et al. Risk of lymphoma in inflammatory bowel disease. Am J Gastroenterol 2000; 95: 2308-12.
138. Sato M, Ishida H, Konno K, et al. Abdominal involvement in neurofibromatosis 1: somographic findings. Abdom Imaging 2000; 25: 517-22.
139. Finkle HI. Small bowel intussusception caused by lymphomatous polyposis in a patient with AIDS. Am J Gastroenterol 1997; 92: 726-7.
140. Griffioen G, Bus PJ, Vasen HF, et al. Extracolonic manifestations of familial adenomatous polyposis: desmoid tumors, and upper gastrointestinal adenomas and carcinomas. Scand J Gastroenterol Suppl 1998; 225: 85-91.
141. Ryan JC. Premalignant conditions of the small intestine. Semin Gastrointest Dis 1996; 7: 88-93.
142. Shibata C, Sasaki I, Naito H, et al. Turcot syndrome with colonic obstruction and small intestinal invagination: report of a case. Surg Today 1999; 29: 785-8.
143. Watanabe T, Kudo M, Shirane H, et al. Cronkhite-Canada syndrome associated with triple gastric cancers: a case report. Gastrointest Endosc 1999; 50: 688-91.
144. Cho KC, Sundaram K, Sebastiano LS. Filiform polyposis of the small bowel in a patient with multiple hamartoma syndrome (Cowden disease). Am J Roentgenol 1999; 173: 501-2.
145. Berger A, Cellier C, Daniel C, et al. Small bowel metastasis from primary carcinoma of the lung: clinical findings and outcome. Am J Gastroenterol 1999; 94: 1884-7.
146. Blecker D, Abraham S, Furth EE, et al. Melanoma in the gastrointestinal tract. Am J Gastroenterol 1999; 94: 3427-33.
147. Schuchter LM, Green R, Fraker D. Primary and metastatic diseases in malignant melanoma of the gastrointestinal tract. Curr Opin Oncol 2000; 12: 181-5.
148. Elsayed AM, Albahra M, Nzeako UC, et al. Malignant melanomas in the small intestine: a study of 103 patients. Am J Gastroenterol 1996; 91: 1001-6.
149. Wade TP, Goodwin MN, Countryman DM, et al. Small bowel melanoma: extended survival with surgical management. Eur J Surg Oncol 1995; 21: 90-1.
|
Language: | English.
|
Document Type: | Clinical Reviews: The Small Intestine and Nutrition.
|
Journal Subset: | Clinical Medicine.
|
ISSN: | 0192-0790
|
NLM Journal Code: | ibg, 7910017
|
Annotation(s) | |
|
|